You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
透雲生物(01332.HK)建議採納新購股權計劃及終止現有購股權計劃
格隆匯 04-24 21:35

格隆匯4月24日丨透雲生物(01332.HK)公吿,現有購股權計劃乃於2022年6月2日獲公司採納,有效期為採納日期起計十年。根據現有購股權計劃的條款,公司可隨時於股東大會上通過決議案終止現有購股權計劃,在此情況下不得進一步授出購股權,惟購股權計劃的條文將繼續有效,以使在終止前已授出或可能根據現有購股權計劃條文須予行使的任何購股權可繼續行使。在終止前根據現有購股權計劃授出的購股權應繼續有效,並可根據現有購股權計劃的規則行使。

於本公吿日期,有355,968,000份根據現有購股權計劃已授出但尚未行使的購股權。由本公吿日期起至股東周年大會召開日止期間,董事會無意根據現有購股權計劃進一步授出任何購股權。

上市規則第17章的修訂已自2023年1月1日起生效。為此,公司建議終止現有購股權計劃並採納新購股權計劃,該計劃將自新購股權計劃採納日起為期十年有效。新購股權計劃的條文將符合2023年1月1日起生效的經修訂上市規則第17章的規定。

董事相信,新購股權計劃將有助集團吸引及挽留集團的優秀人才,為合資格參與者提供額外激勵,並促進集團業務的整體成功。此外,新購股權計劃將向合資格參與者提供一個於公司擁有個人權益的機會,有助於激勵合資格參與者提高其表現及效率,並吸引及挽留對集團長遠增長及盈利能力有重要貢獻的合資格參與者。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account